144 related articles for article (PubMed ID: 35178364)
1. Mortality among Alaska Native Adults with Confirmed Hepatitis C Virus Infection Compared with the General Population in Alaska, 1995-2016.
Bressler SS; Bruden D; Nolen LD; Bruce MG; Towshend-Bulson L; Spradling P; McMahon BJ
Can J Gastroenterol Hepatol; 2022; 2022():2573545. PubMed ID: 35178364
[TBL] [Abstract][Full Text] [Related]
2. Infection With Hepatitis C Virus Genotype 3 Is an Independent Risk Factor for End-Stage Liver Disease, Hepatocellular Carcinoma, and Liver-Related Death.
McMahon BJ; Bruden D; Townshend-Bulson L; Simons B; Spradling P; Livingston S; Gove J; Hewitt A; Plotnik J; Homan C; Espera H; Negus S; Snowball M; Barbour Y; Bruce M; Gounder P
Clin Gastroenterol Hepatol; 2017 Mar; 15(3):431-437.e2. PubMed ID: 27765729
[TBL] [Abstract][Full Text] [Related]
3. Adverse outcomes in Alaska natives who recovered from or have chronic hepatitis C infection.
McMahon BJ; Bruden D; Bruce MG; Livingston S; Christensen C; Homan C; Hennessy TW; Williams J; Sullivan D; Rosen HR; Gretch D
Gastroenterology; 2010 Mar; 138(3):922-31.e1. PubMed ID: 19909749
[TBL] [Abstract][Full Text] [Related]
4. Cascade of Care for Alaska Native People With Chronic Hepatitis C Virus Infection: Statewide Program With High Linkage to Care.
Mcmahon BJ; Townshend-Bulson L; Homan C; Gounder P; Barbour Y; Hewitt A; Bruden D; Espera H; Plotnik J; Gove J; Stevenson TJ; Luna SV; Simons BC
Clin Infect Dis; 2020 Apr; 70(9):2005-2007. PubMed ID: 31504307
[TBL] [Abstract][Full Text] [Related]
5. Lower respiratory tract infection hospitalizations among American Indian/Alaska Native adults, Indian Health Service and Alaska Region, 1998-2014.
Bruce MG; Bressler SS; Apostolou A; Singleton RJ
Int J Infect Dis; 2021 Oct; 111():130-137. PubMed ID: 34419583
[TBL] [Abstract][Full Text] [Related]
6. The changing epidemiology and aetiology of hepatocellular carcinoma from 1969 through 2013 in Alaska Native people.
Connelly M; Bruce MG; Bulkow L; Snowball M; McMahon BJ
Liver Int; 2016 Dec; 36(12):1829-1835. PubMed ID: 27224493
[TBL] [Abstract][Full Text] [Related]
7. Mortality rates among individuals diagnosed with hepatitis C virus (HCV); an observational cohort study, England, 2008 to 2016.
Ireland G; Mandal S; Hickman M; Ramsay M; Harris R; Simmons R
Euro Surveill; 2019 Jul; 24(30):. PubMed ID: 31362807
[TBL] [Abstract][Full Text] [Related]
8. Short-Term Incidence of Sequelae of HCV Infection Among Medicaid Beneficiaries in Oregon.
Jindai K; Crawford C; Thomas AR
Public Health Rep; 2019; 134(1):81-88. PubMed ID: 30508493
[TBL] [Abstract][Full Text] [Related]
9. The Alaska Native/American Indian experience of hepatitis C treatment with sofosbuvir-based direct-acting antivirals.
Townshend-Bulson L; Roik E; Barbour Y; Bruden DJT; Homan CE; Espera HGF; Stevenson TJ; Hewitt AM; Rhodes W; Gove JE; Plotnik JN; Snowball MM; McGilvray J; Simons BC; Johnston JM; McMahon BJ
PLoS One; 2021; 16(12):e0260970. PubMed ID: 34855920
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus infection and risk of liver-related and non-liver-related deaths: a population-based cohort study in Naples, southern Italy.
Piselli P; Serraino D; Fusco M; Girardi E; Pirozzi A; Toffolutti F; Cimaglia C; Taborelli M;
BMC Infect Dis; 2021 Jul; 21(1):667. PubMed ID: 34238231
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C Virus Infection and the Temporal Trends in the Risk of Liver Cancer: A National Register-Based Cohort Study in Sweden.
Batyrbekova N; Aleman S; Lybeck C; Montgomery S; Duberg AS
Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):63-70. PubMed ID: 31719064
[TBL] [Abstract][Full Text] [Related]
12. Deaths Associated With Hepatitis C Virus Infection Among Residents in 50 States and the District of Columbia, 2016-2017.
Ly KN; Miniño AM; Liu SJ; Roberts H; Hughes EM; Ward JW; Jiles RB
Clin Infect Dis; 2020 Aug; 71(5):1149-1160. PubMed ID: 31586173
[TBL] [Abstract][Full Text] [Related]
13. Immunological scars after cure of hepatitis C virus infection: Long-HepC?
Cornberg M; Mischke J; Kraft AR; Wedemeyer H
Curr Opin Immunol; 2023 Jun; 82():102324. PubMed ID: 37043890
[TBL] [Abstract][Full Text] [Related]
14. NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
[TBL] [Abstract][Full Text] [Related]
15. Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia.
Alavi M; Law MG; Valerio H; Grebely J; Amin J; Hajarizadeh B; Selvey C; George J; Dore GJ
J Hepatol; 2019 Aug; 71(2):281-288. PubMed ID: 31078544
[TBL] [Abstract][Full Text] [Related]
16. Risk of end-stage liver disease, hepatocellular carcinoma, and liver-related death by fibrosis stage in the hepatitis C Alaska Cohort.
Bruden DJT; McMahon BJ; Townshend-Bulson L; Gounder P; Gove J; Plotnik J; Homan C; Hewitt A; Barbour Y; Spradling PR; Simons BC; McArdle S; Bruce M
Hepatology; 2017 Jul; 66(1):37-45. PubMed ID: 28195349
[TBL] [Abstract][Full Text] [Related]
17. Improved liver transplant waitlist mortality and lower risk of disease progression among chronic hepatitis C patients awaiting liver transplantation after the introduction of direct-acting antiviral therapies in the United States.
Young K; Liu B; Bhuket T; Gish RG; Wong RJ
J Viral Hepat; 2019 Mar; 26(3):350-361. PubMed ID: 30412318
[TBL] [Abstract][Full Text] [Related]
18. Results of interferon-based treatments in Alaska Native and American Indian population with chronic hepatitis C.
Livingston SE; Townshend-Bulson LJ; Bruden DJ; Homan CE; Gove JE; Plotnik JN; Simons BC; Spradling PR; McMahon BJ
Int J Circumpolar Health; 2016; 75():30696. PubMed ID: 27029671
[TBL] [Abstract][Full Text] [Related]
19. Viral eradication reduces all-cause mortality in patients with chronic hepatitis C virus infection: a propensity score analysis.
Tada T; Kumada T; Toyoda H; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Kitabatake S; Yama T; Tanaka J
Liver Int; 2016 Jun; 36(6):817-26. PubMed ID: 26787002
[TBL] [Abstract][Full Text] [Related]
20. Impact of direct-acting antivirals for HCV on mortality in a large population-based cohort study.
Janjua NZ; Wong S; Abdia Y; Jeong D; Buller-Taylor T; Adu PA; Samji H; Wilton J; Pearce M; Butt ZA; Yu A; Binka M; Bartlett S; Alvarez M; Krajden M
J Hepatol; 2021 Nov; 75(5):1049-1057. PubMed ID: 34097994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
